Endpoints News 28 mai 2026 China gene editing startup YolTech raises $70M to move CRISPR therapies forward
Thermo Fisher 28 mai 2026 New Thermo Fisher AI tools aim to speed drug discovery workflows - Stock Titan
Endpoints News 28 mai 2026 AbbVie clinches FDA approval for ultra-rare blood cancer ADC from ImmunoGen purchase
Lonza News 28 mai 2026 Adaptable manufacturing platforms enable in vivo mRNA-LNP delivery, says Lonza - BioXconomy
Abbott 28 mai 2026 Abbott obtains CE mark for duo of glucose-ketone monitors - Medical Device Network
FierceBiotech 28 mai 2026 GSK’s hepatitis B drug cures one-fifth of patients in ‘major step’ for pervasive disease
Qiagen 28 mai 2026 Qiagen N.V. stock (NL0012169213): Diagnostics specialist in focus after latest earnings - AD HOC NEWS
Endpoints News 28 mai 2026 GSK spells out positive Phase 3 data for hepatitis B drug it licensed from Ionis
eLife 28 mai 2026 A novel RAB5 binding site in human VPS34-CII that is likely the primordial site in eukaryotic evolution
eLife 28 mai 2026 Chromosome-scale genome assembly of the European common cuttlefish <i>Sepia officinalis</i>
eLife 28 mai 2026 LFA-1 interaction with GBP-130 on <i>Plasmodium falciparum</i>-infected red blood cells mediates NK cell activation and parasite control